SOURCE: Research and Markets

Research and Markets

April 05, 2016 11:24 ET

Global Combination Inhalers for Upper Airway Diseases Study 2015 -- Market Data and Forecasts for Dual Drug Oral Inhaler Products to 2022

DUBLIN, IRELAND --(Marketwired - April 05, 2016) - Research and Markets has announced the addition of the "Combination Inhalers for Upper Airway Diseases" report to their offering.

Combination inhalers for upper airway diseases -- oral inhalers containing two drugs that complement the therapeutic actions of one another -- have seen a significant increase in development activity and product proliferation in the past five years. Growth is being driven by improved patient experience as derived from ease-of use (fewer devices/medications to administer) and for many patients improved control of symptoms associated with upper airway diseases. Combination inhalers most commonly consist of an inhaled corticosteroid in combination with a bronchodilator. These products are realizing significant commercial success in the two markets for which they are indicated -- Asthma and COPD -- both of which are forecast to grow at impressive rates for the remainder of the decade.

What You Will Learn

- Analyzes the market for combination (dual drug) oral inhalers
- Assesses oral inhalation device technology for delivering multiple drugs, and evaluates product technology issues and evolving market factors
- Provides detailed assessments of combination drug inhalers, their growth prospects and market potential
- Evaluates development-stage dual therapy inhalers and assesses likely market entry timelines
- Provides market data and forecasts for dual drug oral inhaler products to 2022
- Profiles inhaled drug product market participants, their technology, product development activity, and business strategies
- Evaluates the impact of economic, technology, and regulatory factors on inhaled drug companies and their alliance partners

Key Topics Covered:

1. Executive Summary

2. Orally Inhaled Corticosteroid Market Overview

3. The Upper Respiratory Therapeutics Marketspace

4. Asthma Market Risks and Opportunities

5. Global Patient Demographics

6. Inhaler Technologies for Delivering Combination Therapies

7. Dry Powder Inhalers

8. Combination Inhalers - Product Analysis, Market Data & Forecasts

9. Albuterol/Ipratropium (Nebulizer)

10. Development-stage Combination Inhalers

11. Dry Powder Formulations

12. Therapeutic Market Assessment

13. Asthma

14. Market Factors

15. Regulatory Issues

16. Market Sector Company Profiles

For more information visit http://www.researchandmarkets.com/research/b66zn6/combination

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Sector: Inhalers and Nebulisers

Image Available: http://www.marketwire.com/library/MwGo/2016/4/5/11G091881/Images/combination_inhalers_for_upper_airway_diseases-947f36716a59b9d680a73c056233b1b9.jpg

Contact Information

  • CONTACT:
    Research and Markets
    Laura Wood
    Senior Manager
    press@researchandmarkets.com

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716